CLEVELAND, Feb. 16, 2016 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical™ technologies, today announced Barbara Norris will present 'Simplifying the Clinical Trial Regulatory Submissions Process' at SCOPE 2016 on February 23, 2016.
"DATATRAK remains committed to providing industry-leading technology to simplify clinical research," said Scott DeMell, Vice President Sales, DATATRAK. "Our transformational UX CTMS 360™ solution delivers on that promise with a regulatory repository that is easily referenced by trial members and regulatory authorities to monitor and accelerate the submission process."
DATATRAK is a Corporate Sponsor of SCOPE 2016 and will be exhibiting in Booth 600. Barbara Norris will present on Tuesday, February 23, 2016 at 3:20pm EST, included in the 'Adoption and Implementation of Innovative Approaches' track of the 'Clinical IT Strategy and Governance' program.
Book an appointment with DATATRAK to see UX CTMS 360™ in action.
Join DATATRAK Thought Leaders:
Tweet: Simplify the Regulatory Submission process with #DATATRAK at #SCOPE2016. http://ow.ly/YmnZ0
DATATRAK International is a worldwide technology and services company delivering Unified dClinical™ solutions and related services for the clinical trials industry. DATATRAK offers a comprehensive solution on a single, unified platform. The Company delivers a complete portfolio of software products designed to accelerate the collection, analysis and submission of clinical trials. The DATATRAK ONE® software solution, deployed worldwide supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 13, 2015 announcing its results for the full year period ended December 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.